- Review
-
(Epidermal growth factor receptor(EGFR) mutation strongly predicts the response to gefitinib(Iressa, ZD1839) in non-small-cell Lung Cancer)
-
See Won Han, Pil Gyu Hwang, Do Youn Oh, Dong Wan Kim, Doo Hyun Chung, Seock Ah Im, Tae You Kim, Dae Seog Heo, Yung Jue Bang, Noe Kyeong Kim
-
Korean J Med. 2004;67(1):137-138.
-
-
PDF
- Review
-
(Gemcitabine plus Cisplatin as First-Line Chemotherapy in Locally Advanced or Metastatic Biliary Cancer)
-
Tak Yun, Keun Wook Lee, Eun Kee Song, Im Il Na, Hyun Chun Shin, Jee Hyun Kim, Dong Wan Kim, Seock Ah Im, Tae You Kim, Dae Seog Heo, Yung Jue Bang, Noe Kyeong Kim
-
Korean J Med. 2004;67(1):330-331.
-
-
PDF
- Review
-
(FOLFOX-4 as first Line chemotherapy in elderly patients with metastatic colorectal cancer)
-
Do Youn Oh, Yu Jung Kim, Sae Won Han, In Sil Choi, Jee Hyun Kim, Dong Wan Kim, Seock Ah Im, Tae You Kim, Dae Seog Heo, Yung Jue Bang, Noe Kyeong Kim
-
Korean J Med. 2004;67(1):331-332.
-
-
PDF
- Review
-
(Prognostic factors in Glioblastoma multiforme)
-
Tae Min Kim, In Sil Choi, Im Il Na, Hyun Chun Shin, Eun Gi Song, Tak Yun, Keun Wook Lee, Dong Wan Kim, Seock Ah Im, Tae You Kim, Dae Seog Heo, Yung Jue Bang, Neo Kyeong Kim
-
Korean J Med. 2004;67(1):338-339.
-
-
PDF
|
